Venous Thromboembolism after Deep Inferior Epigastric Perforator Flap Breast Reconstruction: Review of Outcomes After a Postoperative Prophylaxis Protocol.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
25 Jul 2023
Historique:
medline: 28 7 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: aheadofprint

Résumé

Deep inferior epigastric perforator (DIEP) flap breast reconstruction is among the higher-risk patient groups for venous thromboembolism (VTE) in plastic surgery. Surgeons often opt for a patient-specific approach to postoperative anticoagulation, and the field has yet to come to a consensus on VTE chemoprophylaxis regimens. A new chemoprophylaxis protocol was introduced starting March 2019 that involved two weeks of treatment with enoxaparin, regardless of patient risk factors. A retrospective chart review was conducted on all patients who underwent DIEP flap breast reconstruction at our institution between January 2014 and March 2020. Patients were grouped based on whether they enrolled in the new VTE protocol in the postoperative period or not. Patient demographics, prophylaxis type, and outcomes data were recorded, retrospectively. The primary outcome measure was postoperative VTE incidence. Risk of VTE was significantly higher in patients discharged without VTE prophylaxis compared to patients discharged with prophylaxis (3.7% vs. 0%, p = 0.03). Notably, zero patients in the VTE prophylaxis group developed a DVT or PE. Additionally, the risk of a VTE event was 25 times greater in patients with a Caprini score greater than or equal to 6 (p=0.0002). We demonstrate the successful implementation of a two-week VTE chemoprophylaxis protocol in DIEP flap breast reconstruction patients that significantly reduces the rate of VTE while not affecting the rate of hematoma complications.

Sections du résumé

BACKGROUND BACKGROUND
Deep inferior epigastric perforator (DIEP) flap breast reconstruction is among the higher-risk patient groups for venous thromboembolism (VTE) in plastic surgery. Surgeons often opt for a patient-specific approach to postoperative anticoagulation, and the field has yet to come to a consensus on VTE chemoprophylaxis regimens.
METHODS METHODS
A new chemoprophylaxis protocol was introduced starting March 2019 that involved two weeks of treatment with enoxaparin, regardless of patient risk factors. A retrospective chart review was conducted on all patients who underwent DIEP flap breast reconstruction at our institution between January 2014 and March 2020. Patients were grouped based on whether they enrolled in the new VTE protocol in the postoperative period or not. Patient demographics, prophylaxis type, and outcomes data were recorded, retrospectively. The primary outcome measure was postoperative VTE incidence.
RESULTS RESULTS
Risk of VTE was significantly higher in patients discharged without VTE prophylaxis compared to patients discharged with prophylaxis (3.7% vs. 0%, p = 0.03). Notably, zero patients in the VTE prophylaxis group developed a DVT or PE. Additionally, the risk of a VTE event was 25 times greater in patients with a Caprini score greater than or equal to 6 (p=0.0002).
CONCLUSIONS CONCLUSIONS
We demonstrate the successful implementation of a two-week VTE chemoprophylaxis protocol in DIEP flap breast reconstruction patients that significantly reduces the rate of VTE while not affecting the rate of hematoma complications.

Identifiants

pubmed: 37506353
doi: 10.1097/PRS.0000000000010949
pii: 00006534-990000000-02054
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 by the American Society of Plastic Surgeons.

Auteurs

Krystle R Tuaño (KR)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Jerry H Yang (JH)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Marlie H Fisher (MH)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Elliot Le (E)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Neil J Khatter (NJ)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Nargis Kalia (N)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Salih Colakoglu (S)

Department of Plastic and Reconstructive Surgery, The Johns Hopkins Hospital, Baltimore, MD, United States.

Justin B Cohen (JB)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Christodoulos Kaoutzanis (C)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Tae W Chong (TW)

Division of Plastic and Reconstructive Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, VA, United States.

David W Mathes (DW)

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado School of Medicine Aurora, CO, United States.

Classifications MeSH